Key result
The endoscopic laser balloon ablation system (HeartLight EAS) introduces a novel laser energy source with direct visual guidance for pulmonary vein isolation in paroxysmal atrial fibrillation.
The endoscopic laser balloon ablation system represents a novel technology for pulmonary vein isolation in paroxysmal atrial fibrillation, featuring direct visual guidance and a new energy source.
Provides visual guidance option for PVI; leaves open comparative efficacy and safety versus established ablation.
Pulmonary vein isolation (PVI) is the basis of all ablation techniques for paroxysmal atrial fibrillation. Performing conventional radiofrequency ablation for PVI is time consuming and sometimes challenging when using point-by-point applications to create continuous lesions. Small electrically conducting gaps evolving in the ablation lines may cause recurrences of atrial fibrillation or regular atrial re-entry tachycardias. Development of novel anatomically designed ablation catheters for PVI aim to facilitate the ablation procedure, to produce continuous and durable lesions with a limited number of ablation impulses and to reduce the complication rate. The endoscopic laser balloon ablation system (HeartLight® EAS, Cardiofocus Inc.) is the first system that allows direct visual guidance of energy delivery at the antral level of each pulmonary vein and uses a completely new energy source for ablation.
No takes yet. Share an insight, caveat, or question.
Schade et al. (2012) conducted a review in paroxysmal atrial fibrillation. Endoscopic laser balloon ablation system (HeartLight EAS) was evaluated. The endoscopic laser balloon ablation system (HeartLight EAS) introduces a novel laser energy source with direct visual guidance for pulmonary vein isolation in paroxysmal atrial fibrillation.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: